Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep;36(9):564-8.

Vorapaxar: targeting a novel antiplatelet pathway

Younos Abdulsattar, Theologia Ternas, Danielle Garcia

Vorapaxar: targeting a novel antiplatelet pathway

Younos Abdulsattar et al. P T. 2011 Sep.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chemical structure of vorapaxar. (From the National Center for Biotechnology Information, National Institutes of Health.9)
See this image and copyright information in PMC

References

    1. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST segment elevation myocardial infarction. J Am Coll Cardiol. 2007;50:1–157. - PubMed
    1. The TRA·CER Executive and Steering Committees The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA·CER) trial: Study design and rationale. Am Heart J. 2009;158:327–334. - PubMed
    1. Bridgewater, N.J.: Bristol Meyers Squibb/Sanofi Pharmaceuticals Partnership; Feb, 2011. Plavix, package insert.
    1. Goto S, Yamaguchi T, Ikeda Y, et al. Safety and exploratory efficacy of the novel thrombin receptor (PAR-1) antagonist SCH530348 for non-ST-segment elevation acute coronary syndrome. J Atheroscler Thromb. 2010;17:156–164. - PubMed
    1. Macaulay TE, Allen C, Ziad KM. Thrombin receptor antagonism: The potential of antiplatelet medication SCH 530348. Exp Opin Pharmacother. 2010;11:1015–1022. - PubMed

LinkOut - more resources